416 related articles for article (PubMed ID: 18355454)
1. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
3. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
4. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
7. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
9. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase and arylesterase activities in fibromyalgia.
Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
[TBL] [Abstract][Full Text] [Related]
12. Assessment of paraoxonase activities in patients with knee osteoarthritis.
Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O
Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
Verit FF; Celik H; Yazgan P; Erel O; Geyikli I
Arch Gynecol Obstet; 2007 May; 275(5):353-9. PubMed ID: 17086419
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase and arylesterase activities in dipper and non-dipper prehypertensive subjects.
Yuksel M; Yildiz A; Tekbas E; Gunduz E; Ekinci A; Bilik MZ; Ozaydogdu N; Atilgan Z
Medicine (Baltimore); 2015 May; 94(17):e786. PubMed ID: 25929926
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
17. DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients.
Gür M; Elbasan Z; Yıldıray Şahin D; Yıldız Koyunsever N; Seker T; Ozaltun B; Caylı M; Kocyigit A
Hypertens Res; 2013 Feb; 36(2):166-71. PubMed ID: 23096232
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
Demirbag R; Sezen Y; Yeşilay AB; Bas M; Yildiz A; Guntekin U; Aksoy N
Coron Artery Dis; 2011 Aug; 22(5):289-93. PubMed ID: 21394024
[TBL] [Abstract][Full Text] [Related]
20. The activity of paraoxonase and arylesterase in patients with osteomyelitis.
Tekin Koruk S; Aksoy N; Hamidanoglu M; Karsen H; Unlu S; Bilinc H
Scand J Clin Lab Invest; 2012 Nov; 72(7):513-7. PubMed ID: 22950624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]